Tin tức & Cập nhật

Low-dose morphine may do more harm than good for COPD patients with chronic breathlessness

Treatment with steady-state, low-dose morphine does not appear to improve sleep efficiency, sleep-disordered breathing frequency, or next-day alertness but may rather result in hypoventilation during sleep in chronic obstructive pulmonary disease (COPD) patients with chronic breathlessness, according to the results of a randomized, double-anonymized, crossover trial.

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

At the Asia Vaccines and Antivirals Summit (AVAS) 2025 held in Bangkok, Thailand, two expert-led sessions provided valuable perspectives on the expanding role of oral antivirals in COVID-19 management. Dr Daniel Griffin, an infectious disease specialist and Clinical Instructor of Medicine at Columbia University, New York, US, focused on protecting high-risk populations through the timely use of antiviral therapy. Complementing this, Professor Ching-Tai Huang of Chang Gung University and Memorial Hospital in Taiwan offered practical guidance on clinical management strategies, including patient risk stratification and therapeutic selection.

Cough variant asthma: A diagnostic challenge with a simple solution

Multiple antibiotic exposures in early life may have long-term respiratory consequences

Preterm infants with multiple episodes of antibiotic exposure prenatally have a higher likelihood of having impaired lung function at early school age, as shown in a study.

Cardiac events common among individuals hospitalized for RSV infection

One in 10 individuals hospitalized for a respiratory syncytial virus (RSV) infection has a concurrent acute cardiovascular event, and this number is higher than that observed among individuals hospitalized for a COVID-19 infection, according to a study from Singapore.

COPD detection refined with new diagnostic schema

Incorporating spirometry with respiratory symptoms and quality of life and structural lung abnormalities on CT imaging to meet criteria for a chronic obstructive pulmonary disease (COPD) diagnosis spots additional patients at risk of poor respiratory outcomes, according to the results of a study presented at the ATS annual meeting and simultaneously published in JAMA.

Cytisinicline confirmed to be efficacious, well-tolerated in smokers set to quit

Cytisinicline’s efficacy and tolerability for smoking cessation has been validated in another large phase III trial conducted in the US, with both the 6- and 12-week treatments yielding positive benefits persisting through 24 weeks.